Cardiovascular Risk in Type 2 Diabetic Patients With Asymptomatic Hyperuricemia and Gout
Aim: To study the differences in cardiovascular risk between type 2 diabetic and non-diabetic patients with asymptomatic hyperuricemia and gout using the Framingham Risk Score (FRS) and complex multimodal ultrasonography.
Saved in:
| Main Authors: | Gancheva R., Kundurdjiev A., Kundurdjiev T., Kolarov Zl. |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Sciendo
2019
|
| Subjects: | |
| Online Access: | https://doaj.org/article/7c70e2637a4f47d7b64054857482709b |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
by: Yousuf Waheed, et al.
Published: (2021) -
Management of hyperuricemia in gout: focus on febuxostat
by: Mattheus K Reinders, et al.
Published: (2010) -
Hyperuricemia as a Risk Factor for Cardiovascular Diseases
by: Ichiro Hisatome, et al.
Published: (2020) -
Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes
by: Palma CCSSV, et al.
Published: (2020) -
Prevalence and Determinants of Hyperuricemia in Type 2 Diabetes Mellitus Patients Attending Jimma Medical Center, Southwestern Ethiopia, 2019
by: Arersa KK, et al.
Published: (2020)